Discovery Park Ventures

The women's health sector is booming, with trailblazers dismantling taboos and filling critical gaps in knowledge and healthcare... Within a crowded market, here are our top 5 game-changing companies: 🧪 Hertility’s at-home hormone and fertility test helps women at every stage of life understand and take charge of their reproductive health. 🍼 BoobyBiome’s pioneering research into the breast milk microbiome is helping ensure that every baby has access to the bacteria needed for healthy development. 💊 Dama Health’s innovative contraception screening is empowering women to make informed reproductive health decisions. 🩸 Flo Health Inc.’s period, ovulation and pregnancy trackers helps women know their body and prepare for menstruation and pregnancy, with symptom calculators and evidence-based information. 🌿 Daye’s diagnostic tampon provides a novel way to screen for STIs and gynaecological microbiome health, while their CBD-infused period-care helps manage period cramps. These companies are not just developing products, they're fostering a new era of open dialogue, research and innovation in women's health. Which other companies should be on our radar? 👀 #femtech #womenshealth #healthcare #healthtech #digitalhealth

Cambridge-based start-up company BugBiome has set out to transform the pest control industry to try to address the various problems caused by current products using a much more sustainable approach based upon microbes. Emma Foster explores how beneficial microbes are being used to create pest-repellent products to aid both the agricultural sector and human health. Read more here 👉 https://lnkd.in/eAfXN99g Ensure you follow our Racing Ahead series for regular insights about innovation and IP in Cambridge. #intellectualproperty #startups #Cambridge

Milking the Mother of All Movements 🐮 To celebrate World Breastfeeding Week this week, we want to shout out to another female-founded company: our friends and fellow scientists over at BoobyBiome who are doing incredible work to translate cutting edge breast milk research into solutions to improve infant health. But they need your help! Hertility's CEO and Founder Dr Helen O'Neill has already donated her breastmilk to further boobybiome's research. So this is a call to urge you to move out from the ovulation station and check into the lactation station by donating your breastmilk (or sharing this with any of your milking friends!)  🍼 It's super simple to do.  🍼 They'll come and collect it from your house and compensate for your time.  🍼 You'll contribute to groundbreaking research, helping boobybiome transform infant health. If you're not breastfeeding, give their page a follow to support their milk mission! Find out more 👉 https://lnkd.in/eE3YfkqX Dr. Sioned Fôn Jones

We are pleased to announce that RS&RS Scientific LTD has joined the prestigious Discovery Park Ventures portfolio! This milestone marks a significant step forward in our mission. A heartfelt thanks to Mayer Schreiber, Emma Palmer Foster, Martino Picardo, and the entire Discovery Park team for their invaluable support. This collaboration will bolster our capabilities and accelerate the development of cutting-edge cancer therapies. We are eager to embark on this journey and make significant strides in our research and innovation. Stay tuned for more updates! #DiscoveryPark #CancerResearch #RSRSScientific #Innovation #Partnership #Biotech

I'm in a video! ⬇ And it's for something really close to my heart. I first heard about BoobyBiome in a CPI meeting about 2 years ago now and it caught my attention immediately. I breastfed my firstborn for 5 weeks. Then, almost without warning, I developed a breast abscess, which left me in agony, with an open wound in my breast, on antibiotics, and very weak. I was told to stop breastfeeding. Working at BioTechniques at the time, I was all too aware of the many benefits of breast milk and emerging research in this area. I had never even considered that I wouldn't be able to breastfeed. I felt, and still feel, a huge amount of guilt about the additional goodness that Freja missed out on by not having access to my breast milk. So, learning about BoobyBiome and the supplement they're developing that contains bacteria isolated from real breast milk was a huge relief to me. I'm so grateful to BoobyBiome for this solution that will help so many parents and babies. What a powerhouse the BoobyBiome team is 👏 I also want to thank all the Mums who contributed and shared their stories to demonstrate the real need for BoobyBiome's products and its monumental lasting impact. Travelling into central London with a new baby is no mean feat. In alignment with both CPI and BoobyBiome's values, we also opened up filming to remote interviews, making it easier and more accessible for mums (including me) to take part. Find out more about how CPI has supported BoobyBiome here: https://lnkd.in/ecqEGBKa Thank you to all involved John George Bader Anna Jopling Dominic Inman Ben Harrison Sarah Williamson Eddie Steinson Clare Trippett Dr. Sioned Fôn Jones Lydia Mapstone, PhD Tara O'Driscoll, PhD Dr Helen O'Neill

We’re thrilled to announce the acquisition of a former Pfizer small molecule API pilot plant in Sandwich, establishing our first manufacturing facility in Europe and expanding our capabilities to meet the needs of global clients. Read more details here: 🔗 https://okt.to/SAx0hQ #pharma #smallmolecule #CDMO #manufacturing

𝗔𝗿𝗲 𝘆𝗼𝘂 𝗮 𝗽𝗮𝘀𝘀𝗶𝗼𝗻𝗮𝘁𝗲 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 𝘄𝗶𝘁𝗵 𝗲𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 𝗶𝗻 𝗺𝗶𝗰𝗿𝗼𝗯𝗶𝗼𝗹𝗼𝗴𝘆, 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗯𝗶𝗼𝗹𝗼𝗴𝘆, 𝗮𝗻𝗱/𝗼𝗿 𝗲𝗻𝘁𝗼𝗺𝗼𝗹𝗼𝗴𝘆 𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝘁𝗼 𝘄𝗼𝗿𝗸 𝗼𝗻 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗶𝗻𝗴 𝗻𝗲𝘄, 𝘀𝗮𝗳𝗲𝗿 𝗮𝗹𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝘃𝗲𝘀 𝘁𝗼 𝘁𝗿𝗮𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝘁𝗼 𝗶𝗻𝘀𝗲𝗰𝘁𝗶𝗰𝗶𝗱𝗲𝘀? We are on the lookout for a senior scientist to join our team to discover novel biopesticides from the microbiome. You will have the opportunity to join a young, ambitious team who are enthusiastic about finding microbial solutions to protect from pests and the infections they transmit. We are looking for someone with a track record of success in the microbiome, AgriTech or other related sectors and a passion for making a difference in sustainable agriculture!

For anyone interested in starting their entrepreneurial career within the life sciences sector, this is the position for you! Drop me a message if you’d like to know more about the role.

Last week I had the pleasure of representing Neobe Therapeutics at SynBioBeta. It was an incredible few days comnecting with the synthetic biology community around the world, and having the opportunity to reconnect with old friends and making some new ones. Particularly thankful to the BioIndustry Association (BIA) for the opportunity to join the UK pavilion. It was a privilige to help represent UK engineering biology and share some of the work we are doing at Neobe harnessing its power to break down solid tumours. After a few extra days in the bay area full of exciting meetings it’s now time for a brief stop over in Boston on the way back home. If you’re in the area and want to catch up, talk anything immunooncology and/or synbio, or just have a beer - give me a shout!

Our collaborators at CPI have been working hard towards large-scale manufacturing of EndoPore. 2 weeks ago, Vitarka's team visited CPI's manufacturing site in Darlington to witness the 10L cultures producing several grams of our EndoPore delivery proteins. This has been possible due to the hard work of CPI's highly experienced team of scientists, and the project is led by CPI's Gabriela Henriques, supported by Pamela Little and Vitarka's Agnes Szafranek over the past 10 months. This is no small feat, to optimise the Upstream and Downstream analytical processes and get to this level of manufacturing as a startup. And this has been made possible by funding support from Innovate UK through the Transofrming Medicines Manufacturing grant.